US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

1.68

+0.05003.07%

Post-market: 1.680.00000.00%19:30 EDT

Volume:7K

Turnover:11.30K

Market Cap:28.44M

PE:-0.03

High:1.75

Open:1.75

Low:1.64

Close:1.63

52wk High:20.99

52wk Low:1.58

Shares:16.93M

Float Shares:2.15M

Volume Ratio:0.06

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-50.6904

EPS(LYR):-52.5900

ROE:-59.28%

ROA:-19.90%

PB:-1.03

PE(LYR):-0.03

Loading ...

Overview Company News Filings

TransCode Therapeutics Updates Preferred Stock Governance Terms

TransCode Therapeutics Shareholders Approve Key Capital Measures

Transcode Therapeutics Holds Annual Shareholder Meeting

TransCode Therapeutics Updates Preferred Stock Ownership Limits

Transcode Therapeutics Adjourns Annual Shareholder Meeting to July 20 Pending NASDAQ Review

TransCode Therapeutics publishes investor presentation on RNA therapeutics, cancer vaccines and oncolytic immunotherapy platforms

TransCode Highlights Progress of Lead RNA Cancer Therapeutic

TransCode Says Phase 1a Cancer Trial Meets Safety Goal, Advances Drug to Phase 2a

MT Newswires Live

TransCode Therapeutics reports Phase 1a trial of TTX-MC138 meets safety endpoint in metastatic cancer

Transcode Therapeutics - Ttx-Mc138 Advances to Phase 2a Clinical Development in Ctdna-Positive Colorectal Cancer

THOMSON REUTERS

Transcode Therapeutics - Phase 1a Trial Meets Safety Endpoint With No Dose-Limiting Toxicities

THOMSON REUTERS

Transcode Therapeutics - Recommended Phase 2a Dose for Ttx-Mc138 Set at 4.8Mg/Kg

THOMSON REUTERS

EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study

Benzinga_recent_news

TransCode Sets Key Deadlines for 2026 Shareholder Meeting

TransCode Therapeutics sets 2026 annual shareholder meeting

Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138

TransCode Therapeutics launches Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients

Transcode Therapeutics Initiates Phase 2a Clinical Trial With Ttx-Mc138 in Patients With Ctdna Positive Colorectal Cancer

THOMSON REUTERS

TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice

TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/RNAZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNAZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":1.68,"timestamp":1790798400000,"preClose":1.63,"halted":0,"volume":6733,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.68,"latestTime":"19:30 EDT","volume":67,"amount":112.5,"timestamp":1790811003196,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0306748466257669,"floatShares":2153200,"shares":16930739,"eps":-50.6904,"marketStatus":"Closed","change":0.05,"latestTime":"09-30 16:00:00 EDT","open":1.7482,"high":1.7482,"low":1.64,"amount":11296.634806299999,"amplitude":0.06638,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-50.6904,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":5,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":1.63,"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.68,"latestTime":"19:30 EDT","volume":67,"amount":112.5,"timestamp":1790811003196,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.064639},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","floatShares":2153200,"roa":"-19.90%","roe":"-59.28%","lyrEps":-52.59,"volumeRatio":0.064639,"shares":16930739,"dividePrice":0,"high":1.7482,"amplitude":0.06638,"preClose":1.63,"low":1.64,"week52Low":1.5785,"pbRate":"-1.03","week52High":20.99,"institutionHeld":0,"latestPrice":1.68,"eps":-50.6904,"divideRate":0,"volume":6733,"delay":0,"ttmEps":-50.6904,"open":1.7482,"prevYearClose":6.83,"prevWeekClose":1.69,"prevMonthClose":2.1,"prevQuarterClose":6.21,"fiveDayClose":1.68,"twentyDayClose":2.06,"sixtyDayClose":8.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RNAZ","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2024-12-04","symbol":"RNAZ","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":33,"toFactor":1,"ratio":33},{"market":"US","date":"2024-01-16","symbol":"RNAZ","defaultRemindTime":1705415400000,"type":"split","dateTimestamp":1705381200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-05-23","symbol":"RNAZ","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2021-08-23","symbol":"RNAZ","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629691200000,"reportTimeType":"","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAZ","date":"2026-09-29","current":-0.03334,"percent":0.252451,"low":-11.279428,"twenty":-1.126562,"median":-0.348734,"eighty":-0.220957,"high":-0.024019,"avg":-1.36827,"sd":2.352608,"marketCap":28951563},"quantilePoints":[{"date":"2021-10-01","current":-9.460165,"twenty":-10.702816,"median":-8.236298,"eighty":-5.217085,"marketCap":36798804},{"date":"2021-10-08","current":-9.096313,"twenty":-10.445875,"median":-8.533995,"eighty":-5.308243,"marketCap":35383466},{"date":"2021-10-15","current":-10.650956,"twenty":-10.598032,"median":-8.782076,"eighty":-5.399402,"marketCap":41430822},{"date":"2021-10-22","current":-9.096313,"twenty":-10.598032,"median":-9.096313,"eighty":-5.459006,"marketCap":35383466},{"date":"2021-10-29","current":-9.360933,"twenty":-10.558339,"median":-9.12939,"eighty":-5.483549,"marketCap":36412803},{"date":"2021-11-05","current":-10.849421,"twenty":-10.750188,"median":-9.228623,"eighty":-5.543153,"marketCap":42202825},{"date":"2021-11-12","current":-9.757863,"twenty":-10.750188,"median":-9.261701,"eighty":-5.557177,"marketCap":37956809},{"date":"2021-11-19","current":-7.259636,"twenty":-10.670802,"median":-9.228623,"eighty":-5.571202,"marketCap":35177810},{"date":"2021-11-26","current":-7.153268,"twenty":-10.611263,"median":-9.162468,"eighty":-5.616781,"marketCap":34662385},{"date":"2021-12-03","current":-7.17986,"twenty":-10.564954,"median":-9.096313,"eighty":-5.686903,"marketCap":34791241},{"date":"2021-12-10","current":-7.153268,"twenty":-10.472337,"median":-8.831693,"eighty":-5.735989,"marketCap":34662385},{"date":"2021-12-17","current":-6.860756,"twenty":-10.419413,"median":-8.60015,"eighty":-5.781568,"marketCap":33244964},{"date":"2021-12-23","current":-7.126676,"twenty":-10.353258,"median":-8.451301,"eighty":-5.809616,"marketCap":34533528},{"date":"2021-12-31","current":-6.754387,"twenty":-10.227564,"median":-8.037833,"eighty":-5.869221,"marketCap":32729538},{"date":"2022-01-07","current":-6.461874,"twenty":-10.148178,"median":-7.959179,"eighty":-6.048032,"marketCap":31312117},{"date":"2022-01-14","current":-6.674611,"twenty":-10.075407,"median":-7.764886,"eighty":-6.28696,"marketCap":32342968},{"date":"2022-01-21","current":-5.398191,"twenty":-10.035714,"median":-7.658518,"eighty":-5.961559,"marketCap":26157859},{"date":"2022-01-28","current":-6.036401,"twenty":-9.943097,"median":-7.405893,"eighty":-5.890049,"marketCap":29250414},{"date":"2022-02-04","current":-6.435282,"twenty":-9.890173,"median":-7.259636,"eighty":-5.961559,"marketCap":31183260},{"date":"2022-02-11","current":-5.517856,"twenty":-9.883557,"median":-7.233044,"eighty":-5.961559,"marketCap":26737713},{"date":"2022-02-18","current":-5.850257,"twenty":-9.85048,"median":-7.17986,"eighty":-5.855575,"marketCap":28348419},{"date":"2022-02-25","current":-5.797072,"twenty":-9.824018,"median":-7.17986,"eighty":-5.802604,"marketCap":28090706},{"date":"2022-03-04","current":-5.956625,"twenty":-9.824018,"median":-7.139972,"eighty":-5.750013,"marketCap":28863844},{"date":"2022-03-11","current":-6.328914,"twenty":-9.757863,"median":-7.012211,"eighty":-5.750013,"marketCap":30667835},{"date":"2022-03-18","current":-6.780979,"twenty":-9.757863,"median":-7.012211,"eighty":-5.743888,"marketCap":32858394},{"date":"2022-03-25","current":-6.54165,"twenty":-9.757863,"median":-6.91394,"eighty":-5.750013,"marketCap":31698686},{"date":"2022-04-01","current":-5.336521,"twenty":-9.757863,"median":-6.953828,"eighty":-5.743888,"marketCap":36519944},{"date":"2022-04-08","current":-5.713661,"twenty":-9.757863,"median":-6.91394,"eighty":-5.690704,"marketCap":39100859},{"date":"2022-04-14","current":-5.406292,"twenty":-9.757863,"median":-6.887347,"eighty":-5.660256,"marketCap":36997413},{"date":"2022-04-22","current":-5.072524,"twenty":-9.704939,"median":-6.840812,"eighty":-5.571315,"marketCap":34713304},{"date":"2022-04-29","current":-5.147952,"twenty":-9.58586,"median":-6.780979,"eighty":-5.549313,"marketCap":35229487},{"date":"2022-05-06","current":-5.214864,"twenty":-9.480012,"median":-6.767683,"eighty":-5.483549,"marketCap":35687393},{"date":"2022-05-13","current":-4.266707,"twenty":-9.460165,"median":-6.754387,"eighty":-5.429601,"marketCap":29198776},{"date":"2022-05-20","current":-4.475575,"twenty":-9.407241,"median":-6.674611,"eighty":-5.404672,"marketCap":26084240},{"date":"2022-05-27","current":-4.074778,"twenty":-9.39401,"median":-6.674611,"eighty":-5.336521,"marketCap":23748338},{"date":"2022-06-03","current":-3.941178,"twenty":-9.374164,"median":-6.621427,"eighty":-5.324634,"marketCap":22969704},{"date":"2022-06-10","current":-3.629447,"twenty":-9.360933,"median":-6.54165,"eighty":-5.272407,"marketCap":21152891},{"date":"2022-06-17","current":-2.671985,"twenty":-9.308563,"median":-6.488466,"eighty":-5.22381,"marketCap":15572680},{"date":"2022-06-24","current":-2.850118,"twenty":-9.26887,"median":-6.461874,"eighty":-5.199367,"marketCap":16610859},{"date":"2022-07-01","current":-2.761052,"twenty":-9.261701,"median":-6.435282,"eighty":-5.137471,"marketCap":16091770},{"date":"2022-07-08","current":-3.094827,"twenty":-9.261701,"median":-6.40869,"eighty":-5.087008,"marketCap":18037057},{"date":"2022-07-15","current":-2.939184,"twenty":-9.261701,"median":-6.328914,"eighty":-4.996097,"marketCap":17129948},{"date":"2022-07-22","current":-2.872384,"twenty":-9.255085,"median":-6.227473,"eighty":-4.960352,"marketCap":16740631},{"date":"2022-07-29","current":-3.161849,"twenty":-9.222007,"median":-6.116177,"eighty":-4.771809,"marketCap":18427672},{"date":"2022-08-05","current":-3.195249,"twenty":-9.18893,"median":-6.116177,"eighty":-4.618082,"marketCap":18622330},{"date":"2022-08-12","current":-2.872384,"twenty":-9.149237,"median":-6.036401,"eighty":-4.456649,"marketCap":16740631},{"date":"2022-08-19","current":-1.241956,"twenty":-9.096313,"median":-6.023105,"eighty":-4.180624,"marketCap":16481087},{"date":"2022-08-26","current":-1.095268,"twenty":-9.096313,"median":-5.942849,"eighty":-4.079231,"marketCap":14534502},{"date":"2022-09-02","current":-1.163722,"twenty":-9.063037,"median":-5.890145,"eighty":-3.972352,"marketCap":15442908},{"date":"2022-09-09","current":-1.105047,"twenty":-8.929933,"median":-5.850257,"eighty":-3.629447,"marketCap":14664274},{"date":"2022-09-16","current":-1.085489,"twenty":-8.831693,"median":-5.802604,"eighty":-3.228649,"marketCap":14404729},{"date":"2022-09-23","current":-1.007256,"twenty":-8.73246,"median":-5.773542,"eighty":-3.161849,"marketCap":13366551},{"date":"2022-09-30","current":-1.07571,"twenty":-8.666305,"median":-5.743888,"eighty":-3.094827,"marketCap":14274957},{"date":"2022-10-07","current":-1.19306,"twenty":-8.533995,"median":-5.702183,"eighty":-3.02825,"marketCap":15832225},{"date":"2022-10-14","current":-1.086467,"twenty":-8.533995,"median":-5.675947,"eighty":-2.983717,"marketCap":14417706},{"date":"2022-10-21","current":-1.065931,"twenty":-8.368608,"median":-5.641175,"eighty":-2.939184,"marketCap":14145185},{"date":"2022-10-28","current":-0.745956,"twenty":-8.103988,"median":-5.574708,"eighty":-2.894651,"marketCap":9899034},{"date":"2022-11-04","current":-0.567192,"twenty":-8.037833,"median":-5.55746,"eighty":-2.872384,"marketCap":7526795},{"date":"2022-11-11","current":-0.513407,"twenty":-8.004215,"median":-5.517856,"eighty":-2.827851,"marketCap":6813047},{"date":"2022-11-18","current":-0.451599,"twenty":-7.99392,"median":-5.495807,"eighty":-2.761052,"marketCap":6877934},{"date":"2022-11-25","current":-0.416494,"twenty":-7.938335,"median":-5.469022,"eighty":-2.688237,"marketCap":6343271},{"date":"2022-12-02","current":-0.366392,"twenty":-7.856382,"median":-5.430806,"eighty":-1.257602,"marketCap":5580210},{"date":"2022-12-09","current":-0.458075,"twenty":-7.779782,"median":-5.420196,"eighty":-1.200883,"marketCap":6976560},{"date":"2022-12-16","current":-0.366392,"twenty":-7.743612,"median":-5.398191,"eighty":-1.173502,"marketCap":5580210},{"date":"2022-12-23","current":-0.30794,"twenty":-7.674473,"median":-5.355378,"eighty":-1.163722,"marketCap":4689972},{"date":"2022-12-30","current":-0.573446,"twenty":-7.610652,"median":-5.336521,"eighty":-1.150031,"marketCap":8733678},{"date":"2023-01-06","current":-0.540811,"twenty":-7.546831,"median":-5.323472,"eighty":-1.138297,"marketCap":8236650},{"date":"2023-01-13","current":-0.521469,"twenty":-7.477691,"median":-5.27995,"eighty":-1.124606,"marketCap":7942067},{"date":"2023-01-20","current":-0.582393,"twenty":-7.419189,"median":-5.261093,"eighty":-1.107003,"marketCap":8869939},{"date":"2023-01-27","current":-0.651837,"twenty":-7.312821,"median":-5.242595,"eighty":-1.095268,"marketCap":9927584},{"date":"2023-02-03","current":-0.533484,"twenty":-7.302184,"median":-5.214864,"eighty":-1.095268,"marketCap":8125046},{"date":"2023-02-10","current":-0.413256,"twenty":-7.259636,"median":-5.168494,"eighty":-1.077744,"marketCap":6293958},{"date":"2023-02-17","current":-0.545246,"twenty":-7.259636,"median":-5.139011,"eighty":-1.058107,"marketCap":8304190},{"date":"2023-02-24","current":-0.446753,"twenty":-7.259636,"median":-5.101383,"eighty":-1.017035,"marketCap":6804119},{"date":"2023-03-03","current":-0.477921,"twenty":-7.259636,"median":-5.078188,"eighty":-0.987697,"marketCap":7278825},{"date":"2023-03-10","current":-0.414545,"twenty":-7.259636,"median":-5.031261,"eighty":-0.742156,"marketCap":6313590},{"date":"2023-03-17","current":-0.336207,"twenty":-7.206452,"median":-4.969511,"eighty":-0.639737,"marketCap":5120495},{"date":"2023-03-24","current":-0.331428,"twenty":-7.206452,"median":-4.960352,"eighty":-0.630535,"marketCap":5047707},{"date":"2023-03-31","current":-0.351688,"twenty":-7.17986,"median":-4.820895,"eighty":-0.589635,"marketCap":5356266},{"date":"2023-04-06","current":-0.45174,"twenty":-7.17986,"median":-4.766672,"eighty":-0.576377,"marketCap":6880072},{"date":"2023-04-14","current":-0.359623,"twenty":-7.17986,"median":-4.653708,"eighty":-0.562385,"marketCap":6316770},{"date":"2023-04-21","current":-0.3153,"twenty":-7.158586,"median":-4.508975,"eighty":-0.54538,"marketCap":5538236},{"date":"2023-04-28","current":-0.301157,"twenty":-7.153268,"median":-4.453309,"eighty":-0.536142,"marketCap":5289807},{"date":"2023-05-05","current":-0.280887,"twenty":-7.131994,"median":-4.257226,"eighty":-0.526923,"marketCap":4933777},{"date":"2023-05-12","current":-0.26233,"twenty":-7.07881,"median":-4.141578,"eighty":-0.517222,"marketCap":4607813},{"date":"2023-05-19","current":-0.244735,"twenty":-7.033024,"median":-4.108178,"eighty":-0.502627,"marketCap":4628383},{"date":"2023-05-26","current":-0.218865,"twenty":-7.012211,"median":-4.052511,"eighty":-0.493236,"marketCap":4139139},{"date":"2023-06-02","current":-0.177519,"twenty":-7.012211,"median":-4.007978,"eighty":-0.484966,"marketCap":3357207},{"date":"2023-06-09","current":-0.429482,"twenty":-7.012211,"median":-3.952311,"eighty":-0.474116,"marketCap":8122289},{"date":"2023-06-16","current":-0.396344,"twenty":-7.012211,"median":-3.629447,"eighty":-0.464845,"marketCap":7495590},{"date":"2023-06-23","current":-0.238101,"twenty":-7.001114,"median":-3.339982,"eighty":-0.453859,"marketCap":4502917},{"date":"2023-06-30","current":-0.230481,"twenty":-6.961806,"median":-3.228649,"eighty":-0.448691,"marketCap":4358824},{"date":"2023-07-07","current":-0.2181,"twenty":-6.91394,"median":-3.195249,"eighty":-0.438648,"marketCap":4124672},{"date":"2023-07-13","current":-0.26953,"twenty":-6.91394,"median":-3.161849,"eighty":-0.429701,"marketCap":5097302},{"date":"2023-07-21","current":-0.235243,"twenty":-6.91394,"median":-3.106183,"eighty":-0.417426,"marketCap":4448882},{"date":"2023-07-28","current":-0.225719,"twenty":-6.91394,"median":-3.072783,"eighty":-0.413256,"marketCap":4268765},{"date":"2023-08-04","current":-0.17429,"twenty":-6.887347,"median":-3.050516,"eighty":-0.400475,"marketCap":3296135},{"date":"2023-08-11","current":-0.160004,"twenty":-6.887347,"median":-3.02825,"eighty":-0.38961,"marketCap":3025960},{"date":"2023-08-18","current":-0.157995,"twenty":-6.860756,"median":-2.972583,"eighty":-0.383263,"marketCap":2935902},{"date":"2023-08-25","current":-0.188589,"twenty":-6.820867,"median":-2.96145,"eighty":-0.363636,"marketCap":3504416},{"date":"2023-09-01","current":-0.158066,"twenty":-6.780979,"median":-2.939184,"eighty":-0.359623,"marketCap":2937227},{"date":"2023-09-08","current":-0.125363,"twenty":-6.780979,"median":-2.905784,"eighty":-0.354845,"marketCap":2329525},{"date":"2023-09-15","current":-0.080668,"twenty":-6.780979,"median":-2.872384,"eighty":-0.351688,"marketCap":1498998},{"date":"2023-09-22","current":-0.07597,"twenty":-6.780979,"median":-2.870157,"eighty":-0.348588,"marketCap":1411692},{"date":"2023-09-29","current":-0.062714,"twenty":-6.759705,"median":-2.827851,"eighty":-0.342044,"marketCap":1165370},{"date":"2023-10-06","current":-0.071025,"twenty":-6.754387,"median":-2.816718,"eighty":-0.335629,"marketCap":1319806},{"date":"2023-10-13","current":-0.069464,"twenty":-6.754387,"median":-2.761052,"eighty":-0.331116,"marketCap":1290799},{"date":"2023-10-20","current":-0.062018,"twenty":-6.722231,"median":-2.715542,"eighty":-0.328027,"marketCap":1152437},{"date":"2023-10-27","current":-0.064937,"twenty":-6.706276,"median":-2.682142,"eighty":-0.320027,"marketCap":1206680},{"date":"2023-11-03","current":-0.394873,"twenty":-6.674611,"median":-1.281073,"eighty":-0.325669,"marketCap":7337632},{"date":"2023-11-10","current":-0.374108,"twenty":-6.674611,"median":-1.222398,"eighty":-0.328975,"marketCap":6951778},{"date":"2023-11-17","current":-0.266701,"twenty":-6.674611,"median":-1.202839,"eighty":-0.325669,"marketCap":5225374},{"date":"2023-11-24","current":-0.246083,"twenty":-6.674611,"median":-1.19306,"eighty":-0.313052,"marketCap":4821413},{"date":"2023-12-01","current":-0.252341,"twenty":-6.648019,"median":-1.173502,"eighty":-0.301157,"marketCap":4944008},{"date":"2023-12-08","current":-0.257476,"twenty":-6.621427,"median":-1.163722,"eighty":-0.294624,"marketCap":5044616},{"date":"2023-12-15","current":-0.216613,"twenty":-6.594835,"median":-1.158832,"eighty":-0.284581,"marketCap":4244003},{"date":"2023-12-22","current":-0.21277,"twenty":-6.54165,"median":-1.144164,"eighty":-0.278188,"marketCap":4168710},{"date":"2023-12-29","current":-0.219174,"twenty":-6.54165,"median":-1.144164,"eighty":-0.276419,"marketCap":4294198},{"date":"2024-01-05","current":-0.187022,"twenty":-6.536278,"median":-1.134385,"eighty":-0.272473,"marketCap":3664249},{"date":"2024-01-12","current":-0.174212,"twenty":-6.509527,"median":-1.129495,"eighty":-0.267111,"marketCap":3413273},{"date":"2024-01-19","current":-0.034907,"twenty":-6.488466,"median":-1.124606,"eighty":-0.258101,"marketCap":683918},{"date":"2024-01-26","current":-0.245163,"twenty":-6.461874,"median":-1.105047,"eighty":-0.25511,"marketCap":4803378},{"date":"2024-02-02","current":-0.228731,"twenty":-6.461874,"median":-1.100157,"eighty":-0.252387,"marketCap":4481445},{"date":"2024-02-09","current":-0.226015,"twenty":-6.435282,"median":-1.095268,"eighty":-0.249824,"marketCap":4428227},{"date":"2024-02-16","current":-0.222025,"twenty":-6.435282,"median":-1.095268,"eighty":-0.245163,"marketCap":4350044},{"date":"2024-02-23","current":-0.243453,"twenty":-6.435282,"median":-1.085978,"eighty":-0.244479,"marketCap":4769871},{"date":"2024-03-01","current":-0.236277,"twenty":-6.414008,"median":-1.075808,"eighty":-0.242065,"marketCap":4629272},{"date":"2024-03-08","current":-0.244794,"twenty":-6.40869,"median":-1.07082,"eighty":-0.241215,"marketCap":4796151},{"date":"2024-03-15","current":-0.231347,"twenty":-6.37678,"median":-1.054196,"eighty":-0.238072,"marketCap":4532691},{"date":"2024-03-22","current":-0.228698,"twenty":-6.336892,"median":-1.014394,"eighty":-0.236326,"marketCap":4480788},{"date":"2024-03-28","current":-0.227658,"twenty":-6.312959,"median":-1.007207,"eighty":-0.235241,"marketCap":4460421},{"date":"2024-04-05","current":-0.240859,"twenty":-6.270412,"median":-0.835033,"eighty":-0.235103,"marketCap":4466991},{"date":"2024-04-12","current":-0.200193,"twenty":-6.223139,"median":-0.744056,"eighty":-0.234734,"marketCap":3712797},{"date":"2024-04-19","current":-0.157211,"twenty":-6.152029,"median":-0.657161,"eighty":-0.233326,"marketCap":2915642},{"date":"2024-04-26","current":-0.164413,"twenty":-6.116177,"median":-0.637734,"eighty":-0.231025,"marketCap":3049227},{"date":"2024-05-03","current":-0.232846,"twenty":-6.116177,"median":-0.632224,"eighty":-0.230356,"marketCap":4318393},{"date":"2024-05-10","current":-0.438028,"twenty":-6.116177,"median":-0.613536,"eighty":-0.230455,"marketCap":8123710},{"date":"2024-05-17","current":-0.316863,"twenty":-6.116177,"median":-0.589635,"eighty":-0.230455,"marketCap":5404405},{"date":"2024-05-24","current":-0.539673,"twenty":-6.100222,"median":-0.579751,"eighty":-0.230518,"marketCap":9204653},{"date":"2024-05-31","current":-0.636737,"twenty":-6.068311,"median":-0.584621,"eighty":-0.230864,"marketCap":10860166},{"date":"2024-06-07","current":-0.520261,"twenty":-6.036401,"median":-0.582393,"eighty":-0.231361,"marketCap":8873551},{"date":"2024-06-14","current":-0.45814,"twenty":-6.036401,"median":-0.573446,"eighty":-0.231448,"marketCap":7814022},{"date":"2024-06-21","current":-0.396019,"twenty":-6.036401,"median":-0.567192,"eighty":-0.231716,"marketCap":6754494},{"date":"2024-06-28","current":-0.392137,"twenty":-6.025764,"median":-0.562969,"eighty":-0.231716,"marketCap":6688273},{"date":"2024-07-05","current":-0.337043,"twenty":-5.999172,"median":-0.562107,"eighty":-0.231942,"marketCap":5748604},{"date":"2024-07-12","current":-0.37061,"twenty":-5.95387,"median":-0.549375,"eighty":-0.233157,"marketCap":6321122},{"date":"2024-07-15","current":-0.365073,"twenty":-5.951115,"median":-0.545413,"eighty":-0.233467,"marketCap":6226668},{"date":"2024-08-02","current":-0.279596,"twenty":-5.948359,"median":-0.54533,"eighty":-0.233778,"marketCap":4768774},{"date":"2024-08-09","current":-0.261577,"twenty":-5.935159,"median":-0.540811,"eighty":-0.23458,"marketCap":4461446},{"date":"2024-08-16","current":-0.241071,"twenty":-5.914078,"median":-0.535146,"eighty":-0.23458,"marketCap":4316414},{"date":"2024-08-23","current":-0.268168,"twenty":-5.887486,"median":-0.528286,"eighty":-0.2347,"marketCap":4801579},{"date":"2024-08-30","current":-0.268843,"twenty":-5.860894,"median":-0.524747,"eighty":-0.23472,"marketCap":4813665},{"date":"2024-09-06","current":-0.265178,"twenty":-5.850257,"median":-0.520013,"eighty":-0.2347,"marketCap":4748055},{"date":"2024-09-13","current":-0.243964,"twenty":-5.838208,"median":-0.51569,"eighty":-0.234714,"marketCap":4368211},{"date":"2024-09-20","current":-0.3645,"twenty":-5.813123,"median":-0.509454,"eighty":-0.234734,"marketCap":6526418},{"date":"2024-09-27","current":-0.593228,"twenty":-5.800391,"median":-0.508517,"eighty":-0.234734,"marketCap":10621832},{"date":"2024-10-04","current":-0.591107,"twenty":-5.797072,"median":-0.509454,"eighty":-0.234734,"marketCap":10583848},{"date":"2024-10-11","current":-0.70335,"twenty":-5.778248,"median":-0.513407,"eighty":-0.234801,"marketCap":12593570},{"date":"2024-10-18","current":-0.577607,"twenty":-5.747563,"median":-0.519765,"eighty":-0.235036,"marketCap":10342129},{"date":"2024-10-25","current":-0.6264,"twenty":-5.743888,"median":-0.521196,"eighty":-0.235239,"marketCap":11215771},{"date":"2024-10-31","current":-0.486,"twenty":-5.738101,"median":-0.521469,"eighty":-0.235434,"marketCap":8701891},{"date":"2024-11-08","current":-0.453214,"twenty":-5.714694,"median":-0.520013,"eighty":-0.236212,"marketCap":8114859},{"date":"2024-11-15","current":-0.337403,"twenty":-5.70907,"median":-0.51569,"eighty":-0.236289,"marketCap":6041253},{"date":"2024-11-22","current":-0.439549,"twenty":-5.690704,"median":-0.509454,"eighty":-0.236554,"marketCap":6560950},{"date":"2024-11-29","current":-0.402534,"twenty":-5.690704,"median":-0.499775,"eighty":-0.237417,"marketCap":6008448},{"date":"2024-12-06","current":-0.30495,"twenty":-5.675947,"median":-0.496415,"eighty":-0.237718,"marketCap":4551848},{"date":"2024-12-13","current":-0.252723,"twenty":-5.664112,"median":-0.493246,"eighty":-0.237958,"marketCap":3772279},{"date":"2024-12-20","current":-0.134949,"twenty":-5.64483,"median":-0.486,"eighty":-0.236338,"marketCap":2014323},{"date":"2024-12-27","current":-0.136351,"twenty":-5.638982,"median":-0.481763,"eighty":-0.235767,"marketCap":2035251},{"date":"2025-01-03","current":-0.123732,"twenty":-5.621565,"median":-0.477921,"eighty":-0.234835,"marketCap":1846899},{"date":"2025-01-10","current":-0.120227,"twenty":-5.59644,"median":-0.477553,"eighty":-0.234734,"marketCap":1794579},{"date":"2025-01-17","current":-0.117423,"twenty":-5.567922,"median":-0.472095,"eighty":-0.233467,"marketCap":1752723},{"date":"2025-01-24","current":-0.192784,"twenty":-5.557744,"median":-0.467653,"eighty":-0.231448,"marketCap":2877605},{"date":"2025-01-31","current":-0.375492,"twenty":-5.557631,"median":-0.466511,"eighty":-0.231716,"marketCap":5604804},{"date":"2025-02-07","current":-0.530353,"twenty":-5.557177,"median":-0.46549,"eighty":-0.231942,"marketCap":7916351},{"date":"2025-02-14","current":-0.497235,"twenty":-5.549313,"median":-0.466511,"eighty":-0.233157,"marketCap":7422014},{"date":"2025-02-21","current":-0.437063,"twenty":-5.517856,"median":-0.466511,"eighty":-0.234399,"marketCap":6523853},{"date":"2025-02-28","current":-0.117545,"twenty":-5.50456,"median":-0.464726,"eighty":-0.231716,"marketCap":1754547},{"date":"2025-03-07","current":-0.07883,"twenty":-5.50456,"median":-0.459919,"eighty":-0.230702,"marketCap":1176660},{"date":"2025-03-14","current":-0.034611,"twenty":-5.487055,"median":-0.45816,"eighty":-0.230267,"marketCap":516616},{"date":"2025-03-21","current":-0.035917,"twenty":-5.469524,"median":-0.455272,"eighty":-0.228053,"marketCap":536111},{"date":"2025-03-28","current":-0.813147,"twenty":-5.46852,"median":-0.454243,"eighty":-0.227692,"marketCap":12137494},{"date":"2025-04-04","current":-0.722763,"twenty":-5.46852,"median":-0.45814,"eighty":-0.227692,"marketCap":10788365},{"date":"2025-04-11","current":-0.623309,"twenty":-5.430806,"median":-0.459919,"eighty":-0.228053,"marketCap":9303856},{"date":"2025-04-17","current":-0.496779,"twenty":-5.425988,"median":-0.463616,"eighty":-0.228569,"marketCap":8323520},{"date":"2025-04-25","current":-0.55724,"twenty":-5.423723,"median":-0.459919,"eighty":-0.228724,"marketCap":9336534},{"date":"2025-05-02","current":-0.785708,"twenty":-5.418238,"median":-0.464726,"eighty":-0.228973,"marketCap":13164513},{"date":"2025-05-09","current":-0.487863,"twenty":-5.40842,"median":-0.466511,"eighty":-0.23002,"marketCap":8174135},{"date":"2025-05-16","current":-0.249953,"twenty":-5.399811,"median":-0.467234,"eighty":-0.230385,"marketCap":6377185},{"date":"2025-05-23","current":-0.248972,"twenty":-5.388064,"median":-0.465905,"eighty":-0.230022,"marketCap":6352176},{"date":"2025-05-30","current":-0.225447,"twenty":-5.378754,"median":-0.464376,"eighty":-0.228718,"marketCap":5751971},{"date":"2025-06-06","current":-0.235903,"twenty":-5.351607,"median":-0.459919,"eighty":-0.228718,"marketCap":6018729},{"date":"2025-06-13","current":-0.235413,"twenty":-5.336521,"median":-0.45814,"eighty":-0.228912,"marketCap":6006224},{"date":"2025-06-20","current":-0.228061,"twenty":-5.336521,"median":-0.455272,"eighty":-0.228316,"marketCap":5818660},{"date":"2025-06-27","current":-0.26825,"twenty":-5.333625,"median":-0.451995,"eighty":-0.228711,"marketCap":6844011},{"date":"2025-07-03","current":-0.276091,"twenty":-5.326957,"median":-0.451599,"eighty":-0.228791,"marketCap":7044080},{"date":"2025-07-11","current":-0.294062,"twenty":-5.313893,"median":-0.446753,"eighty":-0.229035,"marketCap":7502571},{"date":"2025-07-18","current":-0.328369,"twenty":-5.295036,"median":-0.443773,"eighty":-0.22914,"marketCap":8377870},{"date":"2025-07-25","current":-0.359437,"twenty":-5.27995,"median":-0.438727,"eighty":-0.229679,"marketCap":9170513},{"date":"2025-08-01","current":-0.362704,"twenty":-5.276179,"median":-0.438196,"eighty":-0.230297,"marketCap":9253881},{"date":"2025-08-08","current":-0.348,"twenty":-5.261093,"median":-0.437433,"eighty":-0.230428,"marketCap":8878723},{"date":"2025-08-15","current":-0.36107,"twenty":-5.261093,"median":-0.435462,"eighty":-0.230493,"marketCap":9212197},{"date":"2025-08-22","current":-0.319249,"twenty":-5.253694,"median":-0.433115,"eighty":-0.230574,"marketCap":7853293},{"date":"2025-08-29","current":-0.334839,"twenty":-5.223953,"median":-0.429592,"eighty":-0.230831,"marketCap":8236788},{"date":"2025-09-05","current":-0.355851,"twenty":-5.223379,"median":-0.426621,"eighty":-0.231347,"marketCap":8753671},{"date":"2025-09-12","current":-0.379574,"twenty":-5.214864,"median":-0.418933,"eighty":-0.231381,"marketCap":9337249},{"date":"2025-09-19","current":-0.380591,"twenty":-5.214864,"median":-0.417216,"eighty":-0.231655,"marketCap":9362260},{"date":"2025-09-26","current":-0.336194,"twenty":-5.189036,"median":-0.415471,"eighty":-0.231716,"marketCap":8270135},{"date":"2025-10-03","current":-0.358562,"twenty":-5.147952,"median":-0.413901,"eighty":-0.231716,"marketCap":8820366},{"date":"2025-10-10","current":-0.500903,"twenty":-5.147952,"median":-0.414143,"eighty":-0.232846,"marketCap":12321834},{"date":"2025-10-17","current":-0.505647,"twenty":-5.139011,"median":-0.415392,"eighty":-0.233289,"marketCap":12438550},{"date":"2025-10-24","current":-0.445322,"twenty":-5.136444,"median":-0.417006,"eighty":-0.234399,"marketCap":10954594},{"date":"2025-10-31","current":-0.371102,"twenty":-5.101383,"median":-0.417216,"eighty":-0.2347,"marketCap":9128828},{"date":"2025-11-07","current":-0.314843,"twenty":-5.09963,"median":-0.415471,"eighty":-0.2347,"marketCap":7744915},{"date":"2025-11-14","current":-0.285359,"twenty":-5.083853,"median":-0.414344,"eighty":-0.234734,"marketCap":7019610},{"date":"2025-11-21","current":-0.263004,"twenty":-5.072524,"median":-0.413256,"eighty":-0.234734,"marketCap":7136326},{"date":"2025-11-28","current":-0.313948,"twenty":-5.067562,"median":-0.411836,"eighty":-0.234734,"marketCap":8518632},{"date":"2025-12-05","current":-0.291836,"twenty":-5.038273,"median":-0.403424,"eighty":-0.234734,"marketCap":7918660},{"date":"2025-12-12","current":-0.352135,"twenty":-4.996097,"median":-0.40212,"eighty":-0.234868,"marketCap":9554806},{"date":"2025-12-19","current":-0.265284,"twenty":-4.980397,"median":-0.400432,"eighty":-0.23517,"marketCap":7198198},{"date":"2025-12-26","current":-0.251091,"twenty":-4.967679,"median":-0.398908,"eighty":-0.235241,"marketCap":6813072},{"date":"2026-01-02","current":-0.230813,"twenty":-4.960352,"median":-0.396262,"eighty":-0.234801,"marketCap":6262850},{"date":"2026-01-09","current":-0.267986,"twenty":-4.960352,"median":-0.395503,"eighty":-0.235024,"marketCap":7271508},{"date":"2026-01-16","current":-0.2984,"twenty":-4.925606,"median":-0.392535,"eighty":-0.235219,"marketCap":8096774},{"date":"2026-01-23","current":-0.314959,"twenty":-4.86998,"median":-0.391393,"eighty":-0.235238,"marketCap":8546085},{"date":"2026-01-30","current":-0.354076,"twenty":-4.841932,"median":-0.390649,"eighty":-0.235277,"marketCap":9607469},{"date":"2026-02-06","current":-0.336926,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"marketCap":9142111},{"date":"2026-02-13","current":-0.333884,"twenty":-4.76765,"median":-0.389142,"eighty":-0.235899,"marketCap":9059584},{"date":"2026-02-20","current":-0.350781,"twenty":-4.76504,"median":-0.388794,"eighty":-0.235903,"marketCap":9518065},{"date":"2026-02-27","current":-0.343684,"twenty":-4.740785,"median":-0.38547,"eighty":-0.236196,"marketCap":9325503},{"date":"2026-03-06","current":-0.315297,"twenty":-4.653708,"median":-0.38427,"eighty":-0.236277,"marketCap":8555255},{"date":"2026-03-13","current":-0.331181,"twenty":-4.609175,"median":-0.383567,"eighty":-0.236338,"marketCap":8986227},{"date":"2026-03-20","current":-0.314622,"twenty":-4.542375,"median":-0.383263,"eighty":-0.237417,"marketCap":8536916},{"date":"2026-03-27","current":-0.2886,"twenty":-4.475575,"median":-0.381152,"eighty":-0.237718,"marketCap":7830855},{"date":"2026-04-02","current":-0.293669,"twenty":-4.471122,"median":-0.379597,"eighty":-0.23791,"marketCap":7968399},{"date":"2026-04-10","current":-0.28894,"twenty":-4.456649,"median":-0.3794,"eighty":-0.238072,"marketCap":7840076},{"date":"2026-04-17","current":-0.230161,"twenty":-4.440562,"median":-0.378211,"eighty":-0.238072,"marketCap":7977621},{"date":"2026-04-24","current":-0.229367,"twenty":-4.300841,"median":-0.375938,"eighty":-0.236326,"marketCap":7950112},{"date":"2026-05-01","current":-0.211907,"twenty":-4.101497,"median":-0.374432,"eighty":-0.235379,"marketCap":7344913},{"date":"2026-05-08","current":-0.202383,"twenty":-3.972352,"median":-0.37178,"eighty":-0.234868,"marketCap":7014805},{"date":"2026-05-15","current":-0.186123,"twenty":-3.803126,"median":-0.369434,"eighty":-0.234714,"marketCap":6451220},{"date":"2026-05-22","current":-0.143979,"twenty":-3.513661,"median":-0.366392,"eighty":-0.233733,"marketCap":5811096},{"date":"2026-05-29","current":-0.124554,"twenty":-3.339982,"median":-0.365679,"eighty":-0.231934,"marketCap":5027097},{"date":"2026-06-05","current":-0.137504,"twenty":-3.331075,"median":-0.364787,"eighty":-0.231354,"marketCap":5549763},{"date":"2026-06-12","current":-0.133972,"twenty":-3.282089,"median":-0.364324,"eighty":-0.230493,"marketCap":5407218},{"date":"2026-06-18","current":-0.125967,"twenty":-3.190796,"median":-0.362868,"eighty":-0.229784,"marketCap":5084115},{"date":"2026-06-26","current":-0.107131,"twenty":-3.144036,"median":-0.362181,"eighty":-0.228724,"marketCap":4323874},{"date":"2026-07-02","current":-0.180121,"twenty":-3.126223,"median":-0.361158,"eighty":-0.227926,"marketCap":7269810},{"date":"2026-07-10","current":-0.225916,"twenty":-3.072783,"median":-0.359601,"eighty":-0.227692,"marketCap":9118147},{"date":"2026-07-17","current":-0.194719,"twenty":-3.02825,"median":-0.358247,"eighty":-0.22682,"marketCap":7858997},{"date":"2026-07-24","current":-0.170703,"twenty":-2.96145,"median":-0.355681,"eighty":-0.225399,"marketCap":6889689},{"date":"2026-07-31","current":-0.123612,"twenty":-2.899104,"median":-0.354076,"eighty":-0.224633,"marketCap":4989085},{"date":"2026-08-07","current":-0.100538,"twenty":-2.868822,"median":-0.352135,"eighty":-0.223319,"marketCap":4057789},{"date":"2026-08-14","current":-0.091265,"twenty":-2.810038,"median":-0.351289,"eighty":-0.221991,"marketCap":3683513},{"date":"2026-08-21","current":-0.073392,"twenty":-2.685345,"median":-0.348734,"eighty":-0.220957,"marketCap":3143688},{"date":"2026-08-28","current":-0.901194,"twenty":-1.210662,"median":-0.348734,"eighty":-0.220957,"marketCap":38602084},{"date":"2026-09-04","current":-0.851787,"twenty":-1.185237,"median":-0.348734,"eighty":-0.220957,"marketCap":36485742},{"date":"2026-09-11","current":-0.667991,"twenty":-1.165678,"median":-0.348734,"eighty":-0.220957,"marketCap":28612948},{"date":"2026-09-18","current":-0.679848,"twenty":-1.14612,"median":-0.348734,"eighty":-0.220957,"marketCap":29120871},{"date":"2026-09-25","current":-0.65218,"twenty":-1.134385,"median":-0.348734,"eighty":-0.220957,"marketCap":27935719},{"date":"2026-09-29","current":-0.675896,"twenty":-1.126562,"median":-0.348734,"eighty":-0.220957,"marketCap":28951563}],"updateTime":1790784488151},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656445302","title":"TransCode Therapeutics Updates Preferred Stock Governance Terms","url":"https://stock-news.laohu8.com/highlight/detail?id=2656445302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656445302?lang=en_us&edition=fundamental","pubTime":"2026-08-04 05:02","pubTimestamp":1785790933,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has shared an announcement. TransCode Therapeutics, Inc., which utilizes Series A and Series B Non-Voting Conver...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-updates-preferred-stock-governance-terms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-updates-preferred-stock-governance-terms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653246978","title":"TransCode Therapeutics Shareholders Approve Key Capital Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2653246978","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653246978?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:51","pubTimestamp":1784580715,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has shared an update. On July 20, 2026, TransCode Therapeutics held its 2026 Annual Meeting of Stockholders, whe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-shareholders-approve-key-capital-measures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-shareholders-approve-key-capital-measures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653245935","title":"Transcode Therapeutics Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2653245935","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653245935?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:17","pubTimestamp":1784578626,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics holds annual shareholder meetingTransCode Therapeutics held its 2026 annual stockholder meeting on July 202, 2026.Stockholders authorized issuance of common stock upon conversio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL6mP6Lc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652333692","title":"TransCode Therapeutics Updates Preferred Stock Ownership Limits","url":"https://stock-news.laohu8.com/highlight/detail?id=2652333692","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652333692?lang=en_us&edition=fundamental","pubTime":"2026-07-18 05:33","pubTimestamp":1784324024,"startTime":"0","endTime":"0","summary":"An announcement from TransCode Therapeutics ( ($RNAZ) ) is now available. On July 16, 2026, TransCode Therapeutics, Inc. amended and restated the c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-updates-preferred-stock-ownership-limits?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-updates-preferred-stock-ownership-limits?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648638497","title":"Transcode Therapeutics Adjourns Annual Shareholder Meeting to July 20 Pending NASDAQ Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2648638497","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648638497?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:07","pubTimestamp":1783022827,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics adjourns annual shareholder meeting to July 20 pending Nasdaq reviewTransCode Therapeutics adjourned its 2026 annual shareholder meeting to July 20 from July 2.Delay tied to Nas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLKmV1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644692087","title":"TransCode Therapeutics publishes investor presentation on RNA therapeutics, cancer vaccines and oncolytic immunotherapy platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2644692087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644692087?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:49","pubTimestamp":1781797794,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics publishes investor presentation on RNA therapeutics, cancer vaccines and oncolytic immunotherapy platforms. Transcode Therapeutics outlined three oncology platforms, led by tumor-targeted RNA therapeutics, alongside vaccine immunotherapies, immuno-oncolytic agents.Lead candidate TTX-MC138, a microRNA-10b antagomiR delivered via iron oxide nanoparticles, is in an active Phase 2a program.Phase 1a in advanced solid tumors: 16 patients treated, about 86 doses, no dose-limiting toxicities through 4.8 mg/kg.Efficacy signals: 9 of 14 evaluable patients had stable disease; 0 complete responses; 0 partial responses; 3 progressive disease.Funding profile: about USD 100 million net invested since the 2021 IPO through financings and grants; no long-term debt.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL4MW07j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644085617","title":"TransCode Highlights Progress of Lead RNA Cancer Therapeutic","url":"https://stock-news.laohu8.com/highlight/detail?id=2644085617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644085617?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:39","pubTimestamp":1781786351,"startTime":"0","endTime":"0","summary":"An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On June 18, 2026, TransCode Therapeutics posted an investor presentation outlin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-highlights-progress-of-lead-rna-cancer-therapeutic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-highlights-progress-of-lead-rna-cancer-therapeutic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAZ","BK4505","BK4539","BK4588","BK4139","BK4097","PRGS","RNA","IE0009354923.USD","BK4585","LU2065732104.USD","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640590262","title":"TransCode Says Phase 1a Cancer Trial Meets Safety Goal, Advances Drug to Phase 2a","url":"https://stock-news.laohu8.com/highlight/detail?id=2640590262","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640590262?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:04","pubTimestamp":1780491877,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics  said Wednesday that its Phase 1a dose-escalation trial of cancer therapy TTX-MC138 met its primary safety endpoint, with no dose-limiting toxicities observed across 16 patients treated.The company said 9 of 14 evaluable patients, or 64%, achieved stable disease lasting at least six months. Three patients remain on treatment, with one receiving therapy for 21 cycles, it added.TTX-MC138, an investigational inhibitor of microRNA-10b, is being developed to target metastatic cancer. TransCode said it selected 4.8 mg/kg as the recommended Phase 2a dose and plans to evaluate the therapy in patients with circulating tumor DNA-positive colorectal cancer following curative-intent treatment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901171","title":"TransCode Therapeutics reports Phase 1a trial of TTX-MC138 meets safety endpoint in metastatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901171","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901171?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:07","pubTimestamp":1780488424,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics completed a Phase 1a dose-escalation trial of TTX-MC138 in metastatic cancer, clearing its safety objective.Patients generally tolerated treatment, with no dose-limiting toxicities reported, supporting a move into Phase 2a development.Several participants achieved durable disease stabilization, including some who remain on therapy.Future scientific congress presentations are planned; a clinical study report is being prepared.Phase 2a will evaluate TTX-MC138 in ctDNA-positive colorectal cancer following curative-intent therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on June 03, 2026, and is solely r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL7DfZ32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901995","title":"Transcode Therapeutics - Ttx-Mc138 Advances to Phase 2a Clinical Development in Ctdna-Positive Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901995?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901961","title":"Transcode Therapeutics - Phase 1a Trial Meets Safety Endpoint With No Dose-Limiting Toxicities","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901961?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640019699","title":"Transcode Therapeutics - Recommended Phase 2a Dose for Ttx-Mc138 Set at 4.8Mg/Kg","url":"https://stock-news.laohu8.com/highlight/detail?id=2640019699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640019699?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:04","pubTimestamp":1780488240,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1LZP5V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904149","title":"EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904149","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904149?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:41","pubTimestamp":1780486860,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/03/Cancer---Heart-Shape-To-Represent-Medica.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,dpr=2,format=auto,quality=85/files/images/story/2026/06/03/Cancer---Heart-Shape-To-Represent-Medica.jpeg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/06/52965529/exclusive-transcodes-rna-therapeutic-achieves-64-stable-disease-rate-in-colorectal-cancer-phase-1-study","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/06/52965529/exclusive-transcodes-rna-therapeutic-achieves-64-stable-disease-rate-in-colorectal-cancer-phase-1-study","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RNAZ","IE0009354923.USD","BK4139","BK4585","RNA","BK4539","BK4505","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640952277","title":"TransCode Sets Key Deadlines for 2026 Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640952277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640952277?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:36","pubTimestamp":1780320993,"startTime":"0","endTime":"0","summary":"The latest announcement is out from TransCode Therapeutics ( ($RNAZ) ). TransCode Therapeutics said it plans to hold its 2026 annual meeting of sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-sets-key-deadlines-for-2026-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-sets-key-deadlines-for-2026-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640199954","title":"TransCode Therapeutics sets 2026 annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640199954","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640199954?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:00","pubTimestamp":1780318847,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics will hold its 2026 annual meeting of stockholders on July 2, 2026, in Boston.Stockholders will vote on matters to be presented at the annual meeting, including director nominations submitted for consideration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL19zDgR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638891656","title":"Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138","url":"https://stock-news.laohu8.com/highlight/detail?id=2638891656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638891656?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:31","pubTimestamp":1779892266,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) announced the initiation of its Phase 2a clinical trial. The study is to evaluate TransCode’s lead therapeutic candid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-initiates-phase-2a-clinical-trial-with-ttx-mc138-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-initiates-phase-2a-clinical-trial-with-ttx-mc138-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507033","title":"TransCode Therapeutics launches Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507033","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507033?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:07","pubTimestamp":1779883632,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics launched a Phase 2a trial of TTX-MC138 in ctDNA-positive colorectal cancer patients following curative-intent therapy.Results have not been presented; the study is expected to generate future data on recurrence-risk reduction in minimal residual disease.Trial targets up to 45 patients with no radiographic disease but persistent or new ctDNA positivity, a marker of residual cancer risk.Study runs with Quantum Leap Healthcare Collaborative on the PRE-I-SPY platform, expanding access to established oncology trial sites.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL33GtkT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638750729","title":"Transcode Therapeutics Initiates Phase 2a Clinical Trial With Ttx-Mc138 in Patients With Ctdna Positive Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2638750729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638750729?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:04","pubTimestamp":1779883440,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA1SJPPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637475063","title":"TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2637475063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637475063?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:10","pubTimestamp":1779487852,"startTime":"0","endTime":"0","summary":"An update from TransCode Therapeutics ( ($RNAZ) ) is now available. On May 19, 2026, TransCode Therapeutics disclosed that it received a deficiency...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-receives-nasdaq-listing-deficiency-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-receives-nasdaq-listing-deficiency-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637434434","title":"TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637434434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637434434?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:17","pubTimestamp":1779481051,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics received a Nasdaq deficiency notice on May 19, 2026 for failing to meet the Nasdaq Capital Market’s minimum stockholders’ equity rule.Stockholders’ equity was $1,251,427 as of the quarter ended March 31, 2026, below the $2,500,000 required under Listing Rule 5550.The notice does not trigger an immediate delisting, but the company must submit a compliance plan by July 3, 2026.Nasdaq may grant up to a 180-day extension to regain compliance; failure to secure acceptance or regain compliance could lead to a delisting determination, subject to appeal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL21KqrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}